Activation of the androgen receptor (AR) despite androgen ablation and anti-androgen therapy seems to play a pivotal role in hormone-refractory progression of prostate cancer. The above postulation is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback